This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover which Dividend Etf ranks lowest in fees with a quick fee-focused comparison. Find affordable options and learn how expense ratios affect your returns.
21,760 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
As AI accelerates, blue-collar automation could reshape factory floors. This piece examines which robotics stocks sta...
Bitcoin is showing resilience as oil prices retreat, pointing to a possible shift in risk sentiment. This morning min...
Electric vehicle leaders are increasingly defined by their software and AI capabilities. This guide highlights three ...
A majority of Americans fear AI-driven job losses will push the cost and effort of buying a home out of reach, accord...
As Lumentum and Coherent rally, Onto Innovation could be the next optics supplier to gain. Analysts say the surge ref...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
March’s selling surge has left more than half industry sectors mired in correction territory, prompting fresh bets on...
Ford is retreating from broad EV production while Toyota accelerates its electrification push, setting up a decisive ...
Investors are watching Criteo's early 2026 results to gauge the ad-tech pioneer's progress in privacy-friendly target...
The latest april jobs report shows a modest 115,000 payroll gain with unemployment steady at 4.3%, but revisions and ...
A growing gap between what Social Security takes in and what it pays out could hit retirees hard. Learn who’s at risk...